Overcoming asset transfer challenges during a merger and acquisition (M&A)
In this video, Parexel’s Paul Bridges speaks with Phil Smith about how pharma and biotech can overcome common operational challenges and key considerations for a more successful asset transfer.
Related Insights
Blog
Overcoming risks in Phase 3 trials to accelerate time to market
Jan 22, 2025
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Playbook
Streamlining development in the EU: Strategies for smoother CTA submissions
Feb 27, 2025
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Webinar
Regulatory roadmap for biotechs: Effective strategies for streamlined early phase development
May 6, 2025
Playbook
Early-phase development strategies for navigating regulatory complexity in the EU
Apr 29, 2024
Blog
Proof of product safety and efficacy: how to move ahead successfully in Phase 2 clinical development
Jan 22, 2025
Article
Expedited Pathways Comparisons - US EU CHN
Oct 19, 2021
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021
Webinar
Accelerated Early Phase Decision-Making – Insider Insights to Speed Development
Jan 7, 2025
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Playbook
What emerging trends in the FDA’s most coveted designations might tell us
Feb 8, 2024
Related Insights
Blog
Overcoming risks in Phase 3 trials to accelerate time to market
Jan 22, 2025
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Playbook
Streamlining development in the EU: Strategies for smoother CTA submissions
Feb 27, 2025
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Webinar
Regulatory roadmap for biotechs: Effective strategies for streamlined early phase development
May 6, 2025
Playbook
Early-phase development strategies for navigating regulatory complexity in the EU
Apr 29, 2024
Blog
Proof of product safety and efficacy: how to move ahead successfully in Phase 2 clinical development
Jan 22, 2025
Article
Expedited Pathways Comparisons - US EU CHN
Oct 19, 2021
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021
Webinar
Accelerated Early Phase Decision-Making – Insider Insights to Speed Development
Jan 7, 2025
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Playbook
What emerging trends in the FDA’s most coveted designations might tell us
Feb 8, 2024